<p>在過去一個季度中，10 位分析師對美國醫療房地產投資信託（NYSE: AHR）表達了多種觀點，提供了從看漲到看跌的多樣化意見。</p>
<p>在下面的表格中，您將找到他們最近評級的摘要，揭示了過去 30 天情緒的變化，並與前幾個月進行了比較。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>分析師為美國醫療房地產投資信託設定了 12 個月的價格目標，顯示出平均目標為 54.7 美元，最高預估為 60.00 美元，最低預估為 52.00 美元。觀察到 13.96% 的增長，目前的平均值已從之前的 48.00 美元上升。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769713245_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="價格目標圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769713245_0.png"/></p>
<h2>分析師評級分析：詳細拆解</h2>
<p>通過對最近分析師行動的深入分析，可以清晰地瞭解美國醫療房地產投資信託在金融專家中的地位。下面的摘要概述了關鍵分析師、他們最近的評估以及對評級和價格目標的調整。</p>
<table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Juan Sanabria</td>
<td>BMO Capital</td>
<td>宣佈</td>
<td>超越市場</td>
<td>$55.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>下調</td>
<td>買入</td>
<td>$52.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>上調</td>
<td>買入</td>
<td>$53.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Nick Joseph</td>
<td>Citigroup</td>
<td>上調</td>
<td>中性</td>
<td>$52.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>上調</td>
<td>超配</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>上調</td>
<td>買入</td>
<td>$56.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>上調</td>
<td>行業超配</td>
<td>$55.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Austin Wurschmidt</td>
<td>Keybanc</td>
<td>上調</td>
<td>超配</td>
<td>$55.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>上調</td>
<td>超越市場</td>
<td>$54.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>Citizens</td>
<td>上調</td>
<td>市場超配</td>
<td>$60.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<h3>關鍵見解：</h3>
<ul>
<li><strong>採取的行動：</strong> 針對動態市場條件和公司表現，分析師更新他們的建議。無論是 ‘維持’、‘上調’ 還是 ‘下調’ 他們的立場，均表明他們對美國醫療房地產投資信託近期發展的反應。這一見解提供了分析師對公司當前狀態的快照。</li>
<li><strong>評級：</strong> 提供對預測的見解，分析師賦予定性值，從 ‘超越市場’ 到 ‘表現不佳’。這些評級傳達了對美國醫療房地產投資信託相對於更廣泛市場的相對錶現的期望。</li>
<li><strong>價格目標：</strong> 理解預測，分析師提供美國醫療房地產投資信託未來價值的估計。檢查當前和之前的目標提供了分析師期望變化的見解。</li>
</ul>
<p>通過理解這些分析師評估及相關財務指標，捕捉美國醫療房地產投資信託市場地位的寶貴見解。保持信息靈通，利用我們的評級表做出戰略決策。</p>
<p>隨時瞭解美國醫療房地產投資信託的分析師評級。</p>
<h2>揭示美國醫療房地產投資信託背後的故事</h2>
<p>美國醫療房地產投資信託公司是一家專注於醫療保健的房地產投資信託。它擁有多樣化的臨牀醫療房地產投資組合，專注於醫療辦公樓、專業護理設施、老年住房、醫院和其他醫療相關設施。它有四個可報告的業務部門：綜合老年健康校園、門診醫療、三重淨租賃物業和 SHOP。它通過綜合老年健康校園部門產生大部分收入。</p>
<h3>美國醫療房地產投資信託的財務表現</h3>
<p><strong>市值：</strong> 由於市值受限，該公司在行業平均水平以下。這反映出相對於同行的規模較小。</p>
<p><strong>積極的收入趨勢：</strong> 檢查美國醫療房地產投資信託過去 3 個月的財務數據，揭示了積極的敍述。截止 2025 年 9 月 30 日，該公司實現了顯著的收入增長率，達到 <strong>9.38%</strong>，展示了頂線收益的顯著增加。與競爭對手相比，該公司的增長率低於房地產行業的平均水平。</p>
<p><strong>淨利潤率：</strong> 該公司的淨利潤率表現突出，超過行業平均水平。憑藉 <strong>9.76%</strong> 的令人印象深刻的淨利潤率，該公司展示了強大的盈利能力和有效的成本控制。</p>
<p><strong>股本回報率（ROE）：</strong> 美國醫療房地產投資信託的 ROE 表現突出，超過行業平均水平。憑藉 <strong>2.19%</strong> 的令人印象深刻的 ROE，該公司展示了有效利用股本和強勁的財務表現。</p>
<p><strong>資產回報率（ROA）：</strong> 美國醫療房地產投資信託的 ROA 超過行業標準，突顯了公司的卓越財務表現。憑藉 <strong>1.21%</strong> 的令人印象深刻的 ROA，該公司有效利用其資產以獲得最佳回報。</p>
<p><strong>債務管理：</strong> 該公司保持了平衡的債務管理，債務與股本比率低於行業標準，達到 <strong>0.63</strong>。</p>
<h2>分析師評級：它們是什麼？</h2>
<p>分析師是銀行和金融系統中的專家，通常為特定股票或特定行業報告。這些人研究公司財務報表，參加電話會議和會議，並與相關內部人士交談，以確定股票的分析師評級。通常，分析師每季度對每隻股票進行評級。</p>
<p>一些分析師發佈他們對增長預估、收益和收入等指標的預測，以便為他們的評級提供額外的指導。在使用分析師評級時，重要的是要記住，股票和行業分析師也是人，他們只是向投資者提供自己的意見。</p>
<p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>

<p>10 位分析師對美國醫療房地產投資信託（NYSE:AHR）提供了不同的意見，評級從看漲到看跌不等。12 個月的平均目標價為 54.7 美元，較之前的 48.00 美元有所上升，最高為 60.00 美元，最低為 52.00 美元。最近的行動包括 BMO 資本和 Truist 證券等公司的評級上調和下調。該公司顯示出 9.38% 的正收入增長率和 9.76% 的強淨利潤率。美國醫療房地產投資信託專注於醫療房地產，擁有醫療辦公室和老年住房等物業</p>

<p>10 analysts have expressed a variety of opinions on American Healthcare REIT (NYSE: AHR) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<div class="lb-trans"><p>在過去一個季度中，10 位分析師對美國醫療房地產投資信託（NYSE: AHR）表達了多種觀點，提供了從看漲到看跌的多樣化意見。</p>
</div><p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<div class="lb-trans"><p>在下面的表格中，您將找到他們最近評級的摘要，揭示了過去 30 天情緒的變化，並與前幾個月進行了比較。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>Analysts have set 12-month price targets for American Healthcare REIT, revealing an average target of $54.7, a high estimate of $60.00, and a low estimate of $52.00. Observing a 13.96% increase, the current average has risen from the previous average price target of $48.00.</p>
<div class="lb-trans"><p>分析師為美國醫療房地產投資信託設定了 12 個月的價格目標，顯示出平均目標為 54.7 美元，最高預估為 60.00 美元，最低預估為 52.00 美元。觀察到 13.96% 的增長，目前的平均值已從之前的 48.00 美元上升。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1769713245_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1769713245_0.png"/></p>
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
<div class="lb-trans"><h2>分析師評級分析：詳細拆解</h2>
</div><p>The standing of American Healthcare REIT among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>通過對最近分析師行動的深入分析，可以清晰地瞭解美國醫療房地產投資信託在金融專家中的地位。下面的摘要概述了關鍵分析師、他們最近的評估以及對評級和價格目標的調整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Juan Sanabria</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$55.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$52.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$53.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Nick Joseph</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$56.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Outperform</td>
<td>$55.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Austin Wurschmidt</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$54.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>Citizens</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$60.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Juan Sanabria</td>
<td>BMO Capital</td>
<td>宣佈</td>
<td>超越市場</td>
<td>$55.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>下調</td>
<td>買入</td>
<td>$52.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Michael Lewis</td>
<td>Truist Securities</td>
<td>上調</td>
<td>買入</td>
<td>$53.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Nick Joseph</td>
<td>Citigroup</td>
<td>上調</td>
<td>中性</td>
<td>$52.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Ronald Kamdem</td>
<td>Morgan Stanley</td>
<td>上調</td>
<td>超配</td>
<td>$55.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Michael Goldsmith</td>
<td>UBS</td>
<td>上調</td>
<td>買入</td>
<td>$56.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>上調</td>
<td>行業超配</td>
<td>$55.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Austin Wurschmidt</td>
<td>Keybanc</td>
<td>上調</td>
<td>超配</td>
<td>$55.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Michael Carroll</td>
<td>RBC Capital</td>
<td>上調</td>
<td>超越市場</td>
<td>$54.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>Citizens</td>
<td>上調</td>
<td>市場超配</td>
<td>$60.00</td>
<td>$50.00</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>關鍵見解：</h3>
</div><ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to American Healthcare REIT. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of American Healthcare REIT compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for American Healthcare REIT's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>採取的行動：</strong> 針對動態市場條件和公司表現，分析師更新他們的建議。無論是 ‘維持’、‘上調’ 還是 ‘下調’ 他們的立場，均表明他們對美國醫療房地產投資信託近期發展的反應。這一見解提供了分析師對公司當前狀態的快照。</li>
<li><strong>評級：</strong> 提供對預測的見解，分析師賦予定性值，從 ‘超越市場’ 到 ‘表現不佳’。這些評級傳達了對美國醫療房地產投資信託相對於更廣泛市場的相對錶現的期望。</li>
<li><strong>價格目標：</strong> 理解預測，分析師提供美國醫療房地產投資信託未來價值的估計。檢查當前和之前的目標提供了分析師期望變化的見解。</li>
</ul>
</div><p>Capture valuable insights into American Healthcare REIT's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<div class="lb-trans"><p>通過理解這些分析師評估及相關財務指標，捕捉美國醫療房地產投資信託市場地位的寶貴見解。保持信息靈通，利用我們的評級表做出戰略決策。</p>
</div><p>Stay up to date on American Healthcare REIT analyst ratings.</p>
<div class="lb-trans"><p>隨時瞭解美國醫療房地產投資信託的分析師評級。</p>
</div><h2>Unveiling the Story Behind American Healthcare REIT</h2>
<div class="lb-trans"><h2>揭示美國醫療房地產投資信託背後的故事</h2>
</div><p>American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.</p>
<div class="lb-trans"><p>美國醫療房地產投資信託公司是一家專注於醫療保健的房地產投資信託。它擁有多樣化的臨牀醫療房地產投資組合，專注於醫療辦公樓、專業護理設施、老年住房、醫院和其他醫療相關設施。它有四個可報告的業務部門：綜合老年健康校園、門診醫療、三重淨租賃物業和 SHOP。它通過綜合老年健康校園部門產生大部分收入。</p>
</div><h3>American Healthcare REIT's Financial Performance</h3>
<div class="lb-trans"><h3>美國醫療房地產投資信託的財務表現</h3>
</div><p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<div class="lb-trans"><p><strong>市值：</strong> 由於市值受限，該公司在行業平均水平以下。這反映出相對於同行的規模較小。</p>
</div><p><strong>Positive Revenue Trend:</strong> Examining American Healthcare REIT's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>9.38%</strong> as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Real Estate sector.</p>
<div class="lb-trans"><p><strong>積極的收入趨勢：</strong> 檢查美國醫療房地產投資信託過去 3 個月的財務數據，揭示了積極的敍述。截止 2025 年 9 月 30 日，該公司實現了顯著的收入增長率，達到 <strong>9.38%</strong>，展示了頂線收益的顯著增加。與競爭對手相比，該公司的增長率低於房地產行業的平均水平。</p>
</div><p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>9.76%,</strong> the company showcases strong profitability and effective cost control.</p>
<div class="lb-trans"><p><strong>淨利潤率：</strong> 該公司的淨利潤率表現突出，超過行業平均水平。憑藉 <strong>9.76%</strong> 的令人印象深刻的淨利潤率，該公司展示了強大的盈利能力和有效的成本控制。</p>
</div><p><strong>Return on Equity (ROE):</strong> American Healthcare REIT's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>2.19%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<div class="lb-trans"><p><strong>股本回報率（ROE）：</strong> 美國醫療房地產投資信託的 ROE 表現突出，超過行業平均水平。憑藉 <strong>2.19%</strong> 的令人印象深刻的 ROE，該公司展示了有效利用股本和強勁的財務表現。</p>
</div><p><strong>Return on Assets (ROA):</strong> American Healthcare REIT's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.21%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<div class="lb-trans"><p><strong>資產回報率（ROA）：</strong> 美國醫療房地產投資信託的 ROA 超過行業標準，突顯了公司的卓越財務表現。憑藉 <strong>1.21%</strong> 的令人印象深刻的 ROA，該公司有效利用其資產以獲得最佳回報。</p>
</div><p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.63</strong>.</p>
<div class="lb-trans"><p><strong>債務管理：</strong> 該公司保持了平衡的債務管理，債務與股本比率低於行業標準，達到 <strong>0.63</strong>。</p>
</div><h2>Analyst Ratings: What Are They?</h2>
<div class="lb-trans"><h2>分析師評級：它們是什麼？</h2>
</div><p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.</p>
<div class="lb-trans"><p>分析師是銀行和金融系統中的專家，通常為特定股票或特定行業報告。這些人研究公司財務報表，參加電話會議和會議，並與相關內部人士交談，以確定股票的分析師評級。通常，分析師每季度對每隻股票進行評級。</p>
</div><p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<div class="lb-trans"><p>一些分析師發佈他們對增長預估、收益和收入等指標的預測，以便為他們的評級提供額外的指導。在使用分析師評級時，重要的是要記住，股票和行業分析師也是人，他們只是向投資者提供自己的意見。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>
</div>

分析師對 American Healthcare REIT 未來的預期